BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2202422)

  • 1. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial experience with the use of oral gadolinium-DTPA in nuclear magnetic resonance tomography of the pelvis].
    Hötzinger H; Salbeck R; Toedt C; Beyer HK
    Digitale Bilddiagn; 1990 Jun; 10(2):42-5. PubMed ID: 2208914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
    Vogl T; Dresel S; Schedel H; Markl A; Grevers G; Stelzer S; Lissner J
    Rofo; 1989 May; 150(5):516-22. PubMed ID: 2541475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?].
    Sparenberg A; Hamm B; Hammerer P; Samberger V; Wolf KJ
    Rofo; 1991 Aug; 155(2):117-22. PubMed ID: 1878537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
    Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
    Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI.
    Mirowitz SA; Totty WG; Lee JK
    J Comput Assist Tomogr; 1992; 16(1):120-5. PubMed ID: 1729290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB; Riva A; Berger T; Stura G; Duca S
    Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gd-DTPA in the diagnosis of brain metastasis].
    Kornienko VN; Pronin IN
    Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
    Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
    Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA].
    Nishimura K; Hida S; Nishio Y; Yoshida O; Nakano Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2097-100. PubMed ID: 3239521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.